Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Laczika, K; Mitterbauer, G; Mitterbauer, M; Knobl, P; Schwarzinger, I; Greinix, HT; Rabitsch, W; Fonatsch, C; Mannhalter, C; Lechner, K; Jaeger, U
   Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions
   LEUKEMIA & LYMPHOMA
   
   K. Laczika et al., "Prospective monitoring of minimal residual disease in acute myeloid leukemia with inversion(16) by CBF beta/MYH11 RT-PCR: Implications for a monitoring schedule and for treatment decisions", LEUK LYMPH, 42(5), 2001, pp. 923-931
2. Rintelen, C; Pabinger, I; Bettelheim, P; Lechner, K; Kyrle, PA; Knobl, P; Schneider, B; Mannhalter, C
   Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation
   EUROPEAN JOURNAL OF HAEMATOLOGY
   
   C. Rintelen et al., "Impact of the factor II: G20210A variant on the risk of venous thromboembolism in relatives from families with the factor V: R506Q mutation", EUR J HAEMA, 67(3), 2001, pp. 165-169
3. Kurz, M; Knobl, P; Kalhs, P; Greinix, HT; Hocker, P; Panzer, S
   Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test
   TRANSFUSION
   
   M. Kurz et al., "Platelet-reactive HLA antibodies associated with low posttransfusion platelet increments: a comparison between the monoclonal antibody-specific immobilization of platelet antigens assay and the lymphocytotoxicity test", TRANSFUSION, 41(6), 2001, pp. 771-774
4. Jansen, M; Derfler, K; Horl, WH; Knobl, P
   Treatment of acquired Factor VIII autoantibodies by immunoadsorption
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M. Jansen et al., "Treatment of acquired Factor VIII autoantibodies by immunoadsorption", BR J HAEM, 114(4), 2001, pp. 957-958
5. Jansen, M; Schmaldienst, S; Banyai, S; Quehenberger, P; Pabinger, I; Derfler, K; Horl, WH; Knobl, P
   Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)
   BRITISH JOURNAL OF HAEMATOLOGY
   
   M. Jansen et al., "Treatment of coagulation inhibitors with extracorporeal immunoadsorption (Ig-Therasorb)", BR J HAEM, 112(1), 2001, pp. 91-97
6. Laczika, K; Mitterbauer, G; Weltermann, A; Knobl, P; Thalhammer-Scherrer, R; Haas, OA; Lechner, K; Jaeger, U
   Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)
   LEUKEMIA & LYMPHOMA
   
   K. Laczika et al., "Prolonged third remission in a patient with acute promyelocytic leukemia after consolidation chemotherapy with intermittent intermediate dose Ara-C and maintenance with intermittent all-trans retinoic acid (ATRA)", LEUK LYMPH, 36(5-6), 2000, pp. 625-629
7. Greinix, HT; Loidolt, H; Rabitsch, W; Schulenburg, A; Keil, F; Mitterbauer, M; Laczika, K; Lechner, K; Dieckmann, K; Fischer, G; Jager, U; Rosenmayr, A; Knobl, P; Schwarzinger, I; Hocker, P; Mannhalter, C; Hinterberger, W; Haas, OA; Fonatsch, C; Kalhs, P
   Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia
   ANNALS OF HEMATOLOGY
   
   H.T. Greinix et al., "Excellent disease eradication by myeloablative therapy and stem-cell transplantation in patients with acute myelogenous leukemia", ANN HEMATOL, 79(4), 2000, pp. 206-213
8. Thalhammer-Scherrer, R; Geissler, K; Schwarzinger, I; Chott, A; Gisslinger, H; Knobl, P; Lechner, K; Jager, U
   Fludarabine therapy in Waldenstrom's macroglobulinemia
   ANNALS OF HEMATOLOGY
   
   R. Thalhammer-Scherrer et al., "Fludarabine therapy in Waldenstrom's macroglobulinemia", ANN HEMATOL, 79(10), 2000, pp. 556-559
9. Stoiser, B; Knobl, P; Fonatsch, C; Haas, OA; Mitterbauer, G; Weltermann, A; Geissler, K; Valent, P; Sperr, W; Pabinger, I; Lechner, K; Jaeger, U
   Prognosis of patients with a second relapse of acute myeloid leukemia
   LEUKEMIA
   
   B. Stoiser et al., "Prognosis of patients with a second relapse of acute myeloid leukemia", LEUKEMIA, 14(12), 2000, pp. 2059-2063
10. Schmaldienst, S; Goldammer, A; Spitzauer, S; Derfler, K; Horl, WH; Knobl, P
    Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption
    AMERICAN JOURNAL OF KIDNEY DISEASES
    
    S. Schmaldienst et al., "Local anticoagulation of the extracorporeal circuit with heparin and subsequent neutralization with protamine during immunoadsorption", AM J KIDNEY, 36(3), 2000, pp. 490-497
11. Schulenburg, A; Kalhs, P; Worel, N; Hocker, P; Knobl, P; Greinix, HT
    Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases
    BONE MARROW TRANSPLANTATION
    
    A. Schulenburg et al., "Immunologic recovery of patients given CD34-selected peripheral blood progenitor cell transplantation for malignant diseases", BONE MAR TR, 25(2), 2000, pp. 223-224
12. Exner, M; Thalhammer, R; Kapiotis, S; Mitterbauer, G; Knobl, P; Haas, OA; Jager, U; Schwarzinger, I
    The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?
    CYTOMETRY
    
    M. Exner et al., "The "typical" immunophenotype of acute promyelocytic leukemia (APL-M3): Does it prove true for the M3-variant?", CYTOMETRY, 42(2), 2000, pp. 106-109
13. Geissler, K; Gisslinger, H; Knobl, P; Sperr, W; Valent, P; Dieckmann, K; Chott, A; Potter, R; Lechner, K; Jager, U
    Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience
    WIENER KLINISCHE WOCHENSCHRIFT
    
    K. Geissler et al., "Efficacy of standard treatment in patients with Hodgkin's disease - A single center experience", WIEN KLIN W, 112(14), 2000, pp. 624-628
14. Worel, N; Greinix, HT; Schneider, B; Kurz, M; Rabitsch, W; Knobl, P; Reiter, E; Derfler, K; Fischer, G; Hinterberger, W; Hocker, P; Kalhs, P
    Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems
    TRANSFUSION
    
    N. Worel et al., "Regeneration of erythropoiesis after related- and unrelated-donor BMT or peripheral blood HPC transplantation: a major ABO mismatch means problems", TRANSFUSION, 40(5), 2000, pp. 543-550
15. Kurz, M; Eichelberger, B; Greinix, H; Hocker, P; Kahls, P; Knobl, P; Mayr, WR; Panzer, S
    Platelet antibodies and fever: Their association in multitransfused patients with hemato-oncological diseases
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN
    
    M. Kurz et al., "Platelet antibodies and fever: Their association in multitransfused patients with hemato-oncological diseases", INFUSIONSTH, 26(1), 1999, pp. 34-36
16. Meidlinger, P; Knobl, P; Jager, U; Gisslinger, H; Pabinger, I; Weltermann, A; Lechner, K; Geissler, K
    Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment
    ANNALS OF HEMATOLOGY
    
    P. Meidlinger et al., "Granulocyte colony-stimulating factor-supported combined immunosuppressivetherapy (antilymphocyte globulin, cyclosporine, and methylprednisolone) inpatients with aplastic anemia: tolerability, efficacy, and changes in the progenitor cell compartment", ANN HEMATOL, 78(7), 1999, pp. 299-304
17. Stohlawetz, P; Stiegler, G; Knobl, P; Hocker, P; Panzer, S
    The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions
    ANNALS OF HEMATOLOGY
    
    P. Stohlawetz et al., "The rise of reticulated platelets after intensive chemotherapy for AML reduces the need for platelet transfusions", ANN HEMATOL, 78(6), 1999, pp. 271-273
18. Heis, N; Rintelen, C; Gisslinger, B; Knobl, P; Lechner, K; Gisslinger, H
    The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    N. Heis et al., "The effect of interferon alpha on myeloproliferation and vascular complications in polycythemia vera", EUR J HAEMA, 62(1), 1999, pp. 27-31
19. Gisslinger, H; Rodeghiero, F; Ruggeri, M; Fard, NHV; Mannhalter, C; Papagiannopoulos, M; Rintelen, C; Lalouschek, W; Knobl, P; Lechner, K; Pabinger, I
    Homocysteine levels in polycythaemia vera and essential thrombocythaemia
    BRITISH JOURNAL OF HAEMATOLOGY
    
    H. Gisslinger et al., "Homocysteine levels in polycythaemia vera and essential thrombocythaemia", BR J HAEM, 105(2), 1999, pp. 551-555
20. MUSTAFA S; MANNHALTER C; RINTELEN C; KYRLE PA; KNOBL P; LECHNER K; PABINGER I
    CLINICAL-FEATURES OF THROMBOPHILIA IN FAMILIES WITH GENE DEFECTS IN PROTEIN-C OR PROTEIN-S COMBINED WITH FACTOR-V-LEIDEN
    Blood coagulation & fibrinolysis
    
    S. Mustafa et al., "CLINICAL-FEATURES OF THROMBOPHILIA IN FAMILIES WITH GENE DEFECTS IN PROTEIN-C OR PROTEIN-S COMBINED WITH FACTOR-V-LEIDEN", Blood coagulation & fibrinolysis, 9(1), 1998, pp. 85-89
21. Knobl, P; Lechner, K
    Acquired factor V inhibitors
    BAILLIERES CLINICAL HAEMATOLOGY
    
    P. Knobl e K. Lechner, "Acquired factor V inhibitors", BAIL CLIN H, 11(2), 1998, pp. 305-318
22. WELTERMANN A; PABINGER I; GEISSLER K; JAGER U; GISSLINGER H; KNOBL P; EICHINGER S; KYRLE PA; VALENT P; SPEISER W; SCHWARZINGER I; MANNHALTER C; LECHNER K
    HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS
    Leukemia
    
    A. Weltermann et al., "HYPOFIBRINOGENEMIA IN NON-M3 ACUTE MYELOID-LEUKEMIA - INCIDENCE, CLINICAL AND LABORATORY CHARACTERISTICS AND PROGNOSIS", Leukemia, 12(8), 1998, pp. 1182-1186
23. WELTERMANN A; MITTERBAUER GJ; MITTERBAUER M; HATTEY E; SPEISER W; GISSLINGER H; KNOBL P; EICHINGER S
    DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)
    Wiener Klinische Wochenschrift
    
    A. Weltermann et al., "DISSEMINATED INTRAVASCULAR COAGULATION WI TH EXCESSIVE FIBRINOLYSIS IN A PATIENT WITH METASTATIC ENDOMETRIAL CARCINOMA - INFLUENCE OF VARIOUS TREATMENTS ON THE COAGULOPATHY (A CASE-REPORT)", Wiener Klinische Wochenschrift, 110(2), 1998, pp. 53-57
24. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
    RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR INCREASES LEVELS OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    British Journal of Haematology
    
    K. Geissler et al., "RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR INCREASES LEVELS OF CIRCULATING HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA", British Journal of Haematology, 102(2), 1998, pp. 535-543
25. KNOBL P; RINTELEN C; KORNEK G; WILTSCHKE C; KALHS P; SCHWARZINGER I; GLOBITS S; STAUDINGER T; LACZIKA K; KYRLE P; FRASS M
    PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS
    Intensive care medicine
    
    P. Knobl et al., "PLASMA-EXCHANGE FOR TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA IN CRITICALLY ILL PATIENTS", Intensive care medicine, 23(1), 1997, pp. 44-50
26. GISSLINGER H; RINTELEN C; MUSIL N; KNOBL P; LECHNER K; PABINGER I
    ELEVATED LEVELS OF HOMOCYSTEINE IN PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA
    Thrombosis and haemostasis
    
    H. Gisslinger et al., "ELEVATED LEVELS OF HOMOCYSTEINE IN PATIENTS WITH POLYCYTHEMIA-VERA AND ESSENTIAL THROMBOCYTHEMIA", Thrombosis and haemostasis, 1997, pp. 196-196
27. KNOBL P; RINTELEN C; KORNEK G; WILTSCHKE C; KYRLE P; FRASS M
    THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN CRITICALLY ILL PATIENTS
    Thrombosis and haemostasis
    
    P. Knobl et al., "THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP) IN CRITICALLY ILL PATIENTS", Thrombosis and haemostasis, 1997, pp. 1317-1317
28. SCHUH J; NIESSNER H; PAPAGIANNOPOULOS M; SCHNEIDER B; KNOBL P; PABINGER I
    HYPERHOMOCYSTEINEMIA IS NOT ASSOCIATED WITH POSTOPERATIVE VENOUS THROMBOEMBOLISM IN ORTHOPEDIC-SURGERY
    Thrombosis and haemostasis
    
    J. Schuh et al., "HYPERHOMOCYSTEINEMIA IS NOT ASSOCIATED WITH POSTOPERATIVE VENOUS THROMBOEMBOLISM IN ORTHOPEDIC-SURGERY", Thrombosis and haemostasis, 1997, pp. 2173-2173
29. KNOBL P; TRIBL B; LECHNER K
    ACQUIRED FACTOR-V INHIBITORS - A REVIEW OF THE LITERATURE
    Thrombosis and haemostasis
    
    P. Knobl et al., "ACQUIRED FACTOR-V INHIBITORS - A REVIEW OF THE LITERATURE", Thrombosis and haemostasis, 1997, pp. 2423-2423
30. GEISSLER K; KOLLER E; HUBMANN E; NIEDERWIESER D; HINTERBERGER W; GEISSLER D; KYRLE P; KNOBL P; PABINGER I; THALHAMMER R; SCHWARZINGER I; MANNHALTER C; JAEGER U; HEINZ R; LINKESCH W; LECHNER K
    GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY
    Blood
    
    K. Geissler et al., "GRANULOCYTE-COLONY-STIMULATING FACTOR AS AN ADJUNCT TO INDUCTION CHEMOTHERAPY FOR ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - A RANDOMIZED PHASE-III STUDY", Blood, 90(2), 1997, pp. 590-596
31. GEISSLER K; KABRNA E; STENGG S; SCHWARZINGER I; KNOBL P; VALENT P; EICHINGER S; BARGE A; LECHNER K
    RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR AUGMENTS MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA
    Blood
    
    K. Geissler et al., "RECOMBINANT HUMAN MEGAKARYOCYTE GROWTH AND DEVELOPMENT FACTOR AUGMENTS MOBILIZATION OF HEMATOPOIETIC PROGENITOR CELLS POST CHEMOTHERAPY IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA", Blood, 90(10), 1997, pp. 431-431
32. THALHAMMERSCHERRER R; KNOBL P; KORNINGER L; SCHWARZINGER I
    AUTOMATED 5-PART WHITE-BLOOD-CELL DIFFERENTIAL COUNTS - EFFICIENCY OFSOFTWARE-GENERATED WHITE-BLOOD-CELL SUSPECT FLAGS OF THE HEMATOLOGY-ANALYZERS SYSMEX-SE-9000, SYSMEX-NE-8000, AND COULTER-STKS
    Archives of pathology and laboratory medicine
    
    R. Thalhammerscherrer et al., "AUTOMATED 5-PART WHITE-BLOOD-CELL DIFFERENTIAL COUNTS - EFFICIENCY OFSOFTWARE-GENERATED WHITE-BLOOD-CELL SUSPECT FLAGS OF THE HEMATOLOGY-ANALYZERS SYSMEX-SE-9000, SYSMEX-NE-8000, AND COULTER-STKS", Archives of pathology and laboratory medicine, 121(6), 1997, pp. 573-577
33. HUHMANN IM; WATZKE HH; GEISSLER K; GISSLINGER H; JAGER U; KNOBL P; PABINGER I; KORNINGER L; MANNHALTER C; MITTERBAUER G; SCHWARZINGER I; KALHS P; HAAS OA; LECHNER K
    FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA
    Annals of hematology
    
    I.M. Huhmann et al., "FLAG (FLUDARABINE, CYTOSINE-ARABINOSIDE, G-CSF) FOR REFRACTORY AND RELAPSED ACUTE MYELOID-LEUKEMIA", Annals of hematology, 73(6), 1996, pp. 265-271
34. MITTERBAUER M; FRITZERSZEKERES M; MITTERBAUER G; SIMONITSCH I; KNOBL P; RINTELEN C; SCHWARZINGER I; HAAS OA; SILBERBAUER K; FREY K; BIBUS B; PABINGER I; RADASZKIEWICZ T; LECHNER K; JAEGER U
    SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA
    Annals of hematology
    
    M. Mitterbauer et al., "SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA", Annals of hematology, 73(4), 1996, pp. 189-193
35. THALHAMMER F; GEISSLER K; JAGER U; KYRLE PA; PABINGER I; MITTERBAUER M; GISSLINGER H; KNOBL P; LACZIKA K; SCHNEIDER B; HAAS OA; LECHNER K
    DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY
    Annals of hematology
    
    F. Thalhammer et al., "DURATION OF 2ND COMPLETE REMISSION IN PATIENTS WITH ACUTE MYELOID-LEUKEMIA TREATED WITH CHEMOTHERAPY - A RETROSPECTIVE SINGLE-CENTER STUDY", Annals of hematology, 72(4), 1996, pp. 216-222
36. RINTELEN C; PABINGER I; KNOBL P; LECHNER K; MANNHALTER C
    PROBABILITY OF RECURRENCE OF THROMBOSIS IN PATIENTS WITH AND WITHOUT FACTOR-V LEIDEN
    Thrombosis and haemostasis
    
    C. Rintelen et al., "PROBABILITY OF RECURRENCE OF THROMBOSIS IN PATIENTS WITH AND WITHOUT FACTOR-V LEIDEN", Thrombosis and haemostasis, 75(2), 1996, pp. 229-232
37. KURZ M; GREINIX H; HOCKER P; KALHS P; KNOBL P; MAYR WR; POBER M; PANZER S
    SPECIFICITIES OF ANTIPLATETLET ANTIBODIES IN MULTITRANSFUSED PATIENTSWITH HAEMATO-ONCOLOGICAL DISORDERS
    British Journal of Haematology
    
    M. Kurz et al., "SPECIFICITIES OF ANTIPLATETLET ANTIBODIES IN MULTITRANSFUSED PATIENTSWITH HAEMATO-ONCOLOGICAL DISORDERS", British Journal of Haematology, 95(3), 1996, pp. 564-569
38. RINTELEN C; MANNHALTER C; IRELAND H; LANE DA; KNOBL P; LECHNER K; PABINGER I
    ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN
    British Journal of Haematology
    
    C. Rintelen et al., "ORAL-CONTRACEPTIVES ENHANCE THE RISK OF CLINICAL MANIFESTATION OF VENOUS THROMBOSIS AT A YOUNG AGE IN FEMALES HOMOZYGOUS FOR FACTOR-V LEIDEN", British Journal of Haematology, 93(2), 1996, pp. 487-490
39. WALCHSHOFER S; BAGHESTANIAN M; GAIGER A; KNOBL P; MOSBERGER I; SIMONITSCH I; CHOTT A; LECHNER K; VALENT P; SILLABER C
    ANTIGENIC CHARACTERIZATION OF HUMAN BONE-MARROW ENDOSTEAL CELLS - A STEM-CELL HYPOTHESIS REANALYZED
    Blood
    
    S. Walchshofer et al., "ANTIGENIC CHARACTERIZATION OF HUMAN BONE-MARROW ENDOSTEAL CELLS - A STEM-CELL HYPOTHESIS REANALYZED", Blood, 88(10), 1996, pp. 3249-3249
40. SCHOLTEN C; FODINGER M; MITTERBAUER M; LACZIKA K; MITTERBAUER G; HAAS OA; KNOBL P; SCHWARZINGER I; THALHAMMER R; PURTSCHER B; GEISSLER K; MANNHALTER C; LECHNER K; JAEGER U
    KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA
    Annals of hematology
    
    C. Scholten et al., "KINETICS OF MINIMAL RESIDUAL DISEASE DURING INDUCTION CONSOLIDATION THERAPY IN STANDARD-RISK ADULT B-LINEAGE ACUTE LYMPHOBLASTIC-LEUKEMIA", Annals of hematology, 71(4), 1995, pp. 155-160
41. TRIBL B; KNOBL P; DERFLER K; KAPIOTIS S; ASPOCK G; JAGER U; HORL W; LECHNER K
    RAPID ELIMINATION OF A HIGH-TITER SPONTANEOUS FACTOR-V ANTIBODY BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION AND IMMUNOSUPPRESSION
    Annals of hematology
    
    B. Tribl et al., "RAPID ELIMINATION OF A HIGH-TITER SPONTANEOUS FACTOR-V ANTIBODY BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION AND IMMUNOSUPPRESSION", Annals of hematology, 71(4), 1995, pp. 199-203
42. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIERDOBERSBERGER T; HORL W; LECHNER K; PABINGER I
    ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))
    Thrombosis and haemostasis
    
    P. Knobl et al., "ELIMINATION OF ACQUIRED FACTOR-VIII ANTIBODIES BY EXTRACORPOREAL ANTIBODY-BASED IMMUNOADSORPTION (IG-THERASORB(R))", Thrombosis and haemostasis, 74(4), 1995, pp. 1035-1038
43. RINTELEN C; KNOBL P; OVISSI L; PABINGER I; MANNHALTER C
    FACTOR-V LEIDEN IS NOT A PREDICTIVE PARAMETER FOR RECURRENT THROMBOSIS IN PATIENTS (PTS) WITH A HISTORY OF VENOUS THROMBOSIS (VT)
    Thrombosis and haemostasis
    
    C. Rintelen et al., "FACTOR-V LEIDEN IS NOT A PREDICTIVE PARAMETER FOR RECURRENT THROMBOSIS IN PATIENTS (PTS) WITH A HISTORY OF VENOUS THROMBOSIS (VT)", Thrombosis and haemostasis, 73(6), 1995, pp. 1371-1371
44. KNOBL P; DERFLER K; KORNINGER L; KAPIOTIS S; JAGER U; MAIENDOBERSBERGER T; TRIBL B; SPEISER W; DRUML W; PABINGER I; LECHNER K
    ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS
    Thrombosis and haemostasis
    
    P. Knobl et al., "ELIMINATION OF ACQUIRED INHIBITORS TO FACTOR-VIII AND FACTOR-V WITH IMMUNOSPECIFIC IMMUNOGLOBULIN APHERESIS", Thrombosis and haemostasis, 73(6), 1995, pp. 1423-1423
45. KALHS P; BRUGGER S; SCHWARZINGER I; GREINIX HT; KEIL F; KYRLE PA; KNOBL P; SCHNEIDER B; HOCKER P; LINKESCH W; LECHNER K
    MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION - ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS
    Transplantation
    
    P. Kalhs et al., "MICROANGIOPATHY FOLLOWING ALLOGENEIC MARROW TRANSPLANTATION - ASSOCIATION WITH CYCLOSPORINE AND METHYLPREDNISOLONE FOR GRAFT-VERSUS-HOST DISEASE PROPHYLAXIS", Transplantation, 60(9), 1995, pp. 949-957
46. MITTERBAUER G; FODINGER M; SCHERRER R; KNOBL P; JAGER U; LACZIKA K; SCHWARZINGER I; GAIGER A; GEISSLER K; GREINIX H; KALHS P; LINKESCH W; LECHNER K; MANNHALTER C
    PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA
    British Journal of Haematology
    
    G. Mitterbauer et al., "PCR-MONITORING OF MINIMAL RESIDUAL LEUKEMIA AFTER CONVENTIONAL CHEMOTHERAPY AND BONE-MARROW TRANSPLANTATION IN BCR-ABL-POSITIVE ACUTE LYMPHOBLASTIC-LEUKEMIA", British Journal of Haematology, 89(4), 1995, pp. 937-941
47. RINTELEN C; PABINGER I; KNOBL P; LECHNER K; MANNHALTER C
    ORAL-CONTRACEPTIVES ARE THE MOST IMPORTANT PRECIPITATING FACTOR FOR VENOUS THROMBOSIS IN YOUNG FEMALES HOMOZYGOUS FOR ARG-506 GLN MUTATION IN THE FACTOR-V GENE
    Blood
    
    C. Rintelen et al., "ORAL-CONTRACEPTIVES ARE THE MOST IMPORTANT PRECIPITATING FACTOR FOR VENOUS THROMBOSIS IN YOUNG FEMALES HOMOZYGOUS FOR ARG-506 GLN MUTATION IN THE FACTOR-V GENE", Blood, 86(10), 1995, pp. 788-788
48. GISSLINGER H; RINTELEN C; MANNHALTER C; PABINGER I; GEISSLER K; KNOBL P; EICHINGER S; LECHNER K
    FACTOR-V LEIDEN MUTATION IS NOT A MAJOR CAUSE OF THROMBOTIC TENDENCY IN ESSENTIAL THROMBOCYTHEMIA (ET) AND POLYCYTHEMIA-VERA (PV)
    Blood
    
    H. Gisslinger et al., "FACTOR-V LEIDEN MUTATION IS NOT A MAJOR CAUSE OF THROMBOTIC TENDENCY IN ESSENTIAL THROMBOCYTHEMIA (ET) AND POLYCYTHEMIA-VERA (PV)", Blood, 86(10), 1995, pp. 3167-3167
49. SCHERRER R; BETTELHEIM P; GEISSLER K; JAGER U; KNOBL P; KYRLE PA; LACZIKA K; MITTERBAUER G; NEUMANN E; SCHNEIDER B; SCHWARZINGER I; LECHNER K
    HIGH EFFICACY OF THE GERMAN MULTICENTER ALL (GMALL) PROTOCOL FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A SINGLE-INSTITUTION STUDY
    Annals of hematology
    
    R. Scherrer et al., "HIGH EFFICACY OF THE GERMAN MULTICENTER ALL (GMALL) PROTOCOL FOR TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A SINGLE-INSTITUTION STUDY", Annals of hematology, 69(4), 1994, pp. 181-188
50. KUSEC R; LACZIKA K; KNOBL P; FRIEDL J; GREINIX H; KAHLS P; LINKESCH W; SCHWARZINGER I; MITTERBAUER G; PURTSCHER B; HAAS OA; LECHNER K; JAEGER U
    AML1 ETO FUSION MESSENGER-RNA CAN BE DETECTED IN REMISSION BLOOD-SAMPLES OF ALL PATIENTS WITH T(821) ACUTE MYELOID-LEUKEMIA AFTER CHEMOTHERAPY OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION/
    Leukemia
    
    R. Kusec et al., "AML1 ETO FUSION MESSENGER-RNA CAN BE DETECTED IN REMISSION BLOOD-SAMPLES OF ALL PATIENTS WITH T(821) ACUTE MYELOID-LEUKEMIA AFTER CHEMOTHERAPY OR AUTOLOGOUS BONE-MARROW TRANSPLANTATION/", Leukemia, 8(5), 1994, pp. 735-739
51. LACZIKA K; MITTERBAUER G; KORNINGER L; KNOBL P; SCHWARZINGER I; KAPIOTIS S; HAAS OA; KYRLE PA; PONT J; OEHLER L; PURTSCHER B; THALHAMMER F; LECHNER K; JAEGER U
    RAPID ACHIEVEMENT OF PML-RAR-ALPHA POLYMERASE CHAIN-REACTION (PCR)-NEGATIVITY BY COMBINED TREATMENT WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA - A PILOT-STUDY
    Leukemia
    
    K. Laczika et al., "RAPID ACHIEVEMENT OF PML-RAR-ALPHA POLYMERASE CHAIN-REACTION (PCR)-NEGATIVITY BY COMBINED TREATMENT WITH ALL-TRANS-RETINOIC ACID AND CHEMOTHERAPY IN ACUTE PROMYELOCYTIC LEUKEMIA - A PILOT-STUDY", Leukemia, 8(1), 1994, pp. 1-5
52. KNOBL P; SCHERNTHANER G; SCHNACK C; PIETSCHMANN P; PROIDL S; PRAGER R; VUKOVICH T
    HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN LEAN TYPE-2 DIABETIC-PATIENTS
    Thrombosis and haemostasis
    
    P. Knobl et al., "HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN LEAN TYPE-2 DIABETIC-PATIENTS", Thrombosis and haemostasis, 71(6), 1994, pp. 692-697
53. KNOBL P; PIETSCHMANN P; SCHNACK C; PRAGER R; SCHERNTHANER G
    APOLIPOPROTEIN(A) LEVELS IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS ARE UNRELATED TO METABOLIC CONTROL OR VASCULAR-DISEASE
    Wiener Klinische Wochenschrift
    
    P. Knobl et al., "APOLIPOPROTEIN(A) LEVELS IN PATIENTS WITH TYPE-1 DIABETES-MELLITUS ARE UNRELATED TO METABOLIC CONTROL OR VASCULAR-DISEASE", Wiener Klinische Wochenschrift, 106(23), 1994, pp. 728-732
54. SCHNACK C; PIETSCHMANN P; KNOBL P; SCHULLER E; PRAGER R; SCHERNTHANER G
    APOLIPOPROTEIN (A) LEVELS AND ATHEROGENIC LIPID FRACTIONS IN RELATIONTO THE DEGREE OF URINARY ALBUMIN EXCRETION IN TYPE-2 DIABETES-MELLITUS
    Nephron
    
    C. Schnack et al., "APOLIPOPROTEIN (A) LEVELS AND ATHEROGENIC LIPID FRACTIONS IN RELATIONTO THE DEGREE OF URINARY ALBUMIN EXCRETION IN TYPE-2 DIABETES-MELLITUS", Nephron, 66(3), 1994, pp. 273-277
55. WILTSCHKE C; KMENT G; SWOBODA H; KNOBL P; KORNEK GV; GLOBITS S; STAUDINGER T; FRASS M
    VENTILATION WITH THE COMBITUBE DURING TRACHEOTOMY
    The Laryngoscope
    
    C. Wiltschke et al., "VENTILATION WITH THE COMBITUBE DURING TRACHEOTOMY", The Laryngoscope, 104(6), 1994, pp. 763-765
56. KORNINGER L; KNOBL P; LACZIKA K; MUSTAFA S; QUEHENBERGER P; SCHWARZINGER I; LECHNER K; JAEGER U; MANNHALTER C
    PML-RAR-ALPHA PCR POSITIVITY IN THE BONE-MARROW OF PATIENTS WITH APL PRECEDES HEMATOLOGICAL RELAPSE BY 2-3 MONTHS
    British Journal of Haematology
    
    L. Korninger et al., "PML-RAR-ALPHA PCR POSITIVITY IN THE BONE-MARROW OF PATIENTS WITH APL PRECEDES HEMATOLOGICAL RELAPSE BY 2-3 MONTHS", British Journal of Haematology, 88(2), 1994, pp. 427-431
57. GEISSLER K; KOLLER E; HINTERBERGER W; NIEDERWIESER D; KNOBL P; PABINGER I; WERNER D; SCHERRER R; SCHWARZINGER I; FRIEDL J; JAEGER U; LECHNER K
    CONCOMITANT ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - 1ST RESULTS OF A MULTICENTER, OPEN-LABEL, PHASE-III STUDY INRANDOMIZED PARALLEL GROUPS
    Blood
    
    K. Geissler et al., "CONCOMITANT ADMINISTRATION OF GRANULOCYTE-COLONY-STIMULATING FACTOR (G-CSF) AND INDUCTION CHEMOTHERAPY OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - 1ST RESULTS OF A MULTICENTER, OPEN-LABEL, PHASE-III STUDY INRANDOMIZED PARALLEL GROUPS", Blood, 84(10), 1994, pp. 10000231-10000231
58. KALHS P; BRUGGER S; SCHWARZINGER I; GREINIX HT; KEIL F; KYRLE PA; KNOBL P; LINKESCH W; LECHNER K
    SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION
    Blood
    
    P. Kalhs et al., "SEVERE MICROANGIOPATHY IN PATIENTS RECEIVING CYCLOSPORINE-A AND METHYLPREDNISOLONE (CSA-MP) FOR GVHD PROPHYLAXIS AFTER ALLOGENEIC MARROW TRANSPLANTATION", Blood, 84(10), 1994, pp. 10000489-10000489
59. KNOBL P; SCHNACK C; PROIDL S; PRAGER R; VUKOVICH T; SCHERNTHANER G
    HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN TYPE-2 DIABETES-MELLITUS
    Thrombosis and haemostasis
    
    P. Knobl et al., "HEMOSTATIC ABNORMALITIES PERSIST DESPITE GLYCEMIC IMPROVEMENT BY INSULIN THERAPY IN TYPE-2 DIABETES-MELLITUS", Thrombosis and haemostasis, 69(6), 1993, pp. 806-806
60. KNOBL P; KAPIOTIS S; LACZIKA K; JAGER U; KYRLE A; SPEISER W; LECHNER K
    ATTENUATION OF THE HEMOSTATIC DISORDER IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID
    Thrombosis and haemostasis
    
    P. Knobl et al., "ATTENUATION OF THE HEMOSTATIC DISORDER IN ACUTE PROMYELOCYTIC LEUKEMIA BY TREATMENT WITH ALL-TRANS-RETINOIC ACID", Thrombosis and haemostasis, 69(6), 1993, pp. 878-878
61. KNOBL P; SCHERNTHANER G; SCHNACK C; PIETSCHMANN P; GRIESMACHER A; PRAGER R; MULLER M
    THROMBOGENIC FACTORS ARE RELATED TO URINARY ALBUMIN EXCRETION RATE INTYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS
    Diabetologia
    
    P. Knobl et al., "THROMBOGENIC FACTORS ARE RELATED TO URINARY ALBUMIN EXCRETION RATE INTYPE-1 (INSULIN-DEPENDENT) AND TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC-PATIENTS", Diabetologia, 36(10), 1993, pp. 1045-1050